Beijing Dabeinong Technology Group Co., Ltd.
Dabei Agricultural Group is an agricultural high-tech enterprise founded by young agricultural intellectuals represented by Dr. Shao Genhuo. Since its establishment in 1993, Dabei Agricultural Group has always adhered to the corporate philosophy of "serving the country and promoting agriculture, striving to be the first, and common development", and is committed to promoting the development of modern agriculture in my country through scientific and technological innovation. In 2010, Dabei Agricultural Group was listed on the Shenzhen Stock Exchange (stock code: 002385), successfully entering the capital market. Dabei Agricultural Group's main business includes six major industries: feed, pig farming, aquatic products, vaccines, crops, and agricultural Internet. It has nearly 20,000 employees, a core R&D team of more than 1,500 people, more than 120 production bases and more than 300 branch companies. , more than 10,000 grassroots science and technology promotion service outlets are built nationwide. The group has 5 national scientific research platforms, 4 national leading agricultural industrialization enterprises, 23 national high-tech enterprises, and has built a Beijing private enterprise academician and expert workstation, and a sub-station of the postdoctoral workstation of Haidian Park, Zhongguancun Science and Technology Park. The feed technology industry is committed to producing feed products, covering pigs, poultry, ruminants and other sectors. It has nearly 100 production bases nationwide, with an annual production capacity of 10 million tons. The pig farming technology industry has nine major pig farming platforms and breeding pig business units nationwide, reserves nearly 30 million pigs for land slaughtered, and owns three national core breeding pig farms. With the goal of "creating a global high-quality aquatic comprehensive service enterprise", the aquatic technology industry has established and planned more than 10 aquatic feed and biotechnology production and R&D bases in Fujian, Hubei, Tianjin and other places. With the goal of "creating a biotechnology enterprise with better quality and services in the world", the vaccine technology industry develops new products such as multi-valent vaccines, genetically engineered vector vaccines, nucleic acid vaccines, new adjuvants, inspection and testing reagents. The crop technology industry focuses on the innovative research and development and service promotion of biotechnology, green varieties, new fertilizers, and environmentally friendly pesticides, and provides farmers with planting technology services in the entire industrial chain. The agricultural Internet industry focuses on the mission of "changing agriculture with the Internet" and has built three core business platforms: "data + e-commerce + finance". In the next ten years, it will meet new backgrounds such as agricultural modernization, biotechnology, mobile Internet, food safety, and global competition. Faced with great opportunities for agricultural change and development, Dabei Agricultural Group has always firmly believed that agriculture is an industry with potential and worthy of struggle. The goal of Dabei Agricultural Group to "create a world agricultural science and technology and service enterprise" will surely be achieved and will definitely contribute more and greater strength to the realization of China's agricultural dream.
Beijing Dabeinong Technology Group Co., Ltd.
Dabei Agricultural Group is an agricultural high-tech enterprise founded by young agricultural intellectuals represented by Dr. Shao Genhuo. Since its establishment in 1993, Dabei Agricultural Group has always adhered to the corporate philosophy of "serving the country and promoting agriculture, striving to be the first, and common development", and is committed to promoting the development of modern agriculture in my country through scientific and technological innovation. In 2010, Dabei Agricultural Group was listed on the Shenzhen Stock Exchange (stock code: 002385), successfully entering the capital market. Dabei Agricultural Group's main business includes six major industries: feed, pig farming, aquatic products, vaccines, crops, and agricultural Internet. It has nearly 20,000 employees, a core R&D team of more than 1,500 people, more than 120 production bases and more than 300 branch companies. , more than 10,000 grassroots science and technology promotion service outlets are built nationwide. The group has 5 national scientific research platforms, 4 national leading agricultural industrialization enterprises, 23 national high-tech enterprises, and has built a Beijing private enterprise academician and expert workstation, and a sub-station of the postdoctoral workstation of Haidian Park, Zhongguancun Science and Technology Park. The feed technology industry is committed to producing feed products, covering pigs, poultry, ruminants and other sectors. It has nearly 100 production bases nationwide, with an annual production capacity of 10 million tons. The pig farming technology industry has nine major pig farming platforms and breeding pig business units nationwide, reserves nearly 30 million pigs for land slaughtered, and owns three national core breeding pig farms. With the goal of "creating a global high-quality aquatic comprehensive service enterprise", the aquatic technology industry has established and planned more than 10 aquatic feed and biotechnology production and R&D bases in Fujian, Hubei, Tianjin and other places. With the goal of "creating a biotechnology enterprise with better quality and services in the world", the vaccine technology industry develops new products such as multi-valent vaccines, genetically engineered vector vaccines, nucleic acid vaccines, new adjuvants, inspection and testing reagents. The crop technology industry focuses on the innovative research and development and service promotion of biotechnology, green varieties, new fertilizers, and environmentally friendly pesticides, and provides farmers with planting technology services in the entire industrial chain. The agricultural Internet industry focuses on the mission of "changing agriculture with the Internet" and has built three core business platforms: "data + e-commerce + finance". In the next ten years, it will meet new backgrounds such as agricultural modernization, biotechnology, mobile Internet, food safety, and global competition. Faced with great opportunities for agricultural change and development, Dabei Agricultural Group has always firmly believed that agriculture is an industry with potential and worthy of struggle. The goal of Dabei Agricultural Group to "create a world agricultural science and technology and service enterprise" will surely be achieved and will definitely contribute more and greater strength to the realization of China's agricultural dream.
Boehringer Ingelheim (China) Investment Co., Ltd.
Fulaien is a well-known brand of dog skin disease deworming drugs, originating from Meria, the world's largest drug research and development and manufacturer in pet health. Frain includes drops and external deworming sprays, and has always been committed to preventing and killing pests, and wholeheartedly protecting the health of love pets. The main ingredients of Flein drops are non-predone and (S) methoxyprotein, and the main ingredients of the spray are non-predone. When dripping on the skin, the agent is stored in the sebaceous glands, forming a "reservoir", and is continuously released to the surface of the skin, spreading through sebum throughout the body; parasites die when they come into contact with the drug.
Boehringer Ingelheim (China) Investment Co., Ltd.
Fulaien is a well-known brand of dog skin disease deworming drugs, originating from Meria, the world's largest drug research and development and manufacturer in pet health. Frain includes drops and external deworming sprays, and has always been committed to preventing and killing pests, and wholeheartedly protecting the health of love pets. The main ingredients of Flein drops are non-predone and (S) methoxyprotein, and the main ingredients of the spray are non-predone. When dripping on the skin, the agent is stored in the sebaceous glands, forming a "reservoir", and is continuously released to the surface of the skin, spreading through sebum throughout the body; parasites die when they come into contact with the drug.
Boehringer Ingelheim (China) Investment Co., Ltd.
Broadline is a newly launched internal and external deworming medicine for cats by Boehringer Ingelheim in 2018. It can effectively kill fleas, ticks, roundworms, hookworms, tapeworms and other common insect diseases in cats. Bolaien innovatively combines four drug components, acetylamide, praziquantel, non-predroni, and (S)-methoxypropene, into one, one is efficient in combating various in vivo and ectoparasitics. Bug, Bolaien gives cats more adequate and complete health protection. Boehringer Ingelheim is a leading global biopharmaceutical company and is headquartered in Ingelheim, Germany. Since its establishment in 1885, Boehringer Ingelheim has been committed to using innovation to demonstrate value and researching breakthrough therapies aimed at improving the health of humans and animals; always respecting animals, humans and the environment, and making animals free by developing solutions and providing services. Disturbing by illness and illness. Boehringer Ingelheim China is headquartered in Shanghai and its core businesses include human medicines, animal health care and biopharmaceutical contract production. The company is currently the leader in the market for pigs, companion animals and poultry products in China. The company has a wide range of layouts in China, covering a complete value chain from R&D, production, sales, technical services to diagnostic monitoring. The company has a professional animal health research and development center and an animal health management center in Shanghai. The company's production base in Nanchang mainly produces poultry vaccine products, which are used to prevent and treat various diseases infected with broiler and laying hens, and provide relevant immunization supporting services. The cutting-edge animal vaccine production base in Asia located in Taizhou, Jiangsu Province is the research and development and production of high-quality pig vaccine products in the Chinese market.
Boehringer Ingelheim (China) Investment Co., Ltd.
Broadline is a newly launched internal and external deworming medicine for cats by Boehringer Ingelheim in 2018. It can effectively kill fleas, ticks, roundworms, hookworms, tapeworms and other common insect diseases in cats. Bolaien innovatively combines four drug components, acetylamide, praziquantel, non-predroni, and (S)-methoxypropene, into one, one is efficient in combating various in vivo and ectoparasitics. Bug, Bolaien gives cats more adequate and complete health protection. Boehringer Ingelheim is a leading global biopharmaceutical company and is headquartered in Ingelheim, Germany. Since its establishment in 1885, Boehringer Ingelheim has been committed to using innovation to demonstrate value and researching breakthrough therapies aimed at improving the health of humans and animals; always respecting animals, humans and the environment, and making animals free by developing solutions and providing services. Disturbing by illness and illness. Boehringer Ingelheim China is headquartered in Shanghai and its core businesses include human medicines, animal health care and biopharmaceutical contract production. The company is currently the leader in the market for pigs, companion animals and poultry products in China. The company has a wide range of layouts in China, covering a complete value chain from R&D, production, sales, technical services to diagnostic monitoring. The company has a professional animal health research and development center and an animal health management center in Shanghai. The company's production base in Nanchang mainly produces poultry vaccine products, which are used to prevent and treat various diseases infected with broiler and laying hens, and provide relevant immunization supporting services. The cutting-edge animal vaccine production base in Asia located in Taizhou, Jiangsu Province is the research and development and production of high-quality pig vaccine products in the Chinese market.
Boehringer Ingelheim (China) Investment Co., Ltd.
Professional antiworming medicine for dogs can effectively solve the problem of parasites inside and outside of Ai Pet. It is a deworming brand under the global animal welfare company Boehringer Ingelheim. It targets ticks, fleas, roundworms, hookworms, whipworms, heartworms, etc. The parasites inside and outside the body have significant effects, achieving rapid absorption, high-speed effect, accurate measurement, safe protection, and comprehensive protection for pet health! Boehringer Ingelheim was founded in 1885 and is still a family business. In the three business areas of human medicine, animal health and biopharmaceutical contract production, about 50,000 employees around the world work hard to show value through innovation every day. Boehringer Ingelheim has always been committed to improving human and animal health, focusing on exploring areas of diseases where effective treatment options have not yet emerged. The company focuses on developing innovative therapies to help patients prolong their lives. In the field of animal health, Boehringer Ingelheim represents advanced prevention programs.
Boehringer Ingelheim (China) Investment Co., Ltd.
Professional antiworming medicine for dogs can effectively solve the problem of parasites inside and outside of Ai Pet. It is a deworming brand under the global animal welfare company Boehringer Ingelheim. It targets ticks, fleas, roundworms, hookworms, whipworms, heartworms, etc. The parasites inside and outside the body have significant effects, achieving rapid absorption, high-speed effect, accurate measurement, safe protection, and comprehensive protection for pet health! Boehringer Ingelheim was founded in 1885 and is still a family business. In the three business areas of human medicine, animal health and biopharmaceutical contract production, about 50,000 employees around the world work hard to show value through innovation every day. Boehringer Ingelheim has always been committed to improving human and animal health, focusing on exploring areas of diseases where effective treatment options have not yet emerged. The company focuses on developing innovative therapies to help patients prolong their lives. In the field of animal health, Boehringer Ingelheim represents advanced prevention programs.
Zhejiang Hisun Pharmaceutical Co., Ltd.
As a subsidiary of Haizheng Pharmaceutical, Haizheng Animal Protection has inherited the spirit and quality of Haizheng Pharmaceutical, and spent 800 million to build an international animal welfare enterprise. It has two major production bases: Fuyang Chemical Pharmaceutical and Kunming vaccines, and has completed the construction of injections and tablets. Multi-dose production line bases such as agents, pouring agents, drops, disinfectants, live bacterial vaccines, bacterial inactivated vaccines, cytotoxic inactivated vaccines, etc. (passed the GMP certification of the Ministry of Agriculture of China and the APVMA certification of the Ministry of Agriculture of Australia), and realized the series Comprehensive development and professionalization. We are committed to research and development, manufacturing, sales and service, adhering to the sacred mission of "Absolute and Good Medicine to Achieve Health Dreams", and provide complete and effective animal health solutions for farm animals and companion animals. Haizheng Pharmaceutical was founded in 1956 and was listed on the A-share market in 2000, focusing on the development of multiple industries such as chemical drugs, biological drugs, animal drugs, traditional Chinese medicines and commercial circulation. Haizheng Pharmaceutical has always followed the vision of "a leading national pharmaceutical industry with sustainable development in globalization". It has 5 major production bases, 600 full-time R&D personnel, and 60+ units of laboratories. It has applied for a total of 1,100 patents, of which 500 authorized patents have been obtained. + Items, providing innovative achievements and high-quality products to the industry. It is a comprehensive pharmaceutical enterprise group integrating research, production and sales value chain, vertical integration of raw materials and preparations.
Zhejiang Hisun Pharmaceutical Co., Ltd.
As a subsidiary of Haizheng Pharmaceutical, Haizheng Animal Protection has inherited the spirit and quality of Haizheng Pharmaceutical, and spent 800 million to build an international animal welfare enterprise. It has two major production bases: Fuyang Chemical Pharmaceutical and Kunming vaccines, and has completed the construction of injections and tablets. Multi-dose production line bases such as agents, pouring agents, drops, disinfectants, live bacterial vaccines, bacterial inactivated vaccines, cytotoxic inactivated vaccines, etc. (passed the GMP certification of the Ministry of Agriculture of China and the APVMA certification of the Ministry of Agriculture of Australia), and realized the series Comprehensive development and professionalization. We are committed to research and development, manufacturing, sales and service, adhering to the sacred mission of "Absolute and Good Medicine to Achieve Health Dreams", and provide complete and effective animal health solutions for farm animals and companion animals. Haizheng Pharmaceutical was founded in 1956 and was listed on the A-share market in 2000, focusing on the development of multiple industries such as chemical drugs, biological drugs, animal drugs, traditional Chinese medicines and commercial circulation. Haizheng Pharmaceutical has always followed the vision of "a leading national pharmaceutical industry with sustainable development in globalization". It has 5 major production bases, 600 full-time R&D personnel, and 60+ units of laboratories. It has applied for a total of 1,100 patents, of which 500 authorized patents have been obtained. + Items, providing innovative achievements and high-quality products to the industry. It is a comprehensive pharmaceutical enterprise group integrating research, production and sales value chain, vertical integration of raw materials and preparations.
Boehringer Ingelheim (China) Investment Co., Ltd.
Boehringer Ingelheim is committed to researching breakthrough therapies aimed at transforming lives and protecting the health of generations. As a global leading pharmaceutical company driven by R&D, the company demonstrates value through innovation in areas where medical needs are highly unmet. Boehringer Ingelheim has been an independent family business since its establishment in 1885 and has always focused on long-term development. In the three major business areas of human medicine, animal health and biopharmaceutical contract production, more than 52,000 employees worldwide serve more than 130 regions.
Boehringer Ingelheim (China) Investment Co., Ltd.
Boehringer Ingelheim is committed to researching breakthrough therapies aimed at transforming lives and protecting the health of generations. As a global leading pharmaceutical company driven by R&D, the company demonstrates value through innovation in areas where medical needs are highly unmet. Boehringer Ingelheim has been an independent family business since its establishment in 1885 and has always focused on long-term development. In the three major business areas of human medicine, animal health and biopharmaceutical contract production, more than 52,000 employees worldwide serve more than 130 regions.
CAHIC Animal Health Co., Ltd.
China Animal Husbandry Industrial Co., Ltd. stock abbreviation: China Animal Husbandry Co., Ltd., stock code: 600195. In November 2004, with the approval of the State-owned Assets Supervision and Administration Commission of the State Council, China Aquatic Products Corporation and China Animal Husbandry Industry and Commerce (Group) Corporation carried out a strategic reorganization to form China Agricultural Development Group The head office, Zhong Agricultural Development Group became the actual controller of Zhong Agricultural Development Co., Ltd. China Animal Husbandry Co., Ltd. now has 8 wholly-owned, controlled and joint venture biological products enterprises, 8 wholly-owned and controlled feed enterprises, and 4 wholly-owned and controlled veterinary medicine enterprises, with a total of more than 3,700 employees. Its business scope includes: animal biological products, feed, feed additives, veterinary medicine and animal husbandry means of production, as well as import and export trade of related products. It is a leading enterprise in China's animal husbandry industry. The company's main products account for more than one-third of the national market share, and the sales volume and market share of its main products are firmly among the top in the country. In 2007, the company achieved main business revenue of 1.721 billion yuan. As of the end of 2007, the company had total assets of 1.805 billion yuan and net assets of 1.097 billion yuan. China Animal Husbandry Co., Ltd. takes the corporate purpose of "protecting animal safety and caring for human health" and is always committed to the development, production, promotion and utilization of new, environmentally friendly, safe and green high-tech products. After years of unremitting efforts, it has been in animal health products and animals. The nutritional products industry has always been at an advanced level.
CAHIC Animal Health Co., Ltd.
China Animal Husbandry Industrial Co., Ltd. stock abbreviation: China Animal Husbandry Co., Ltd., stock code: 600195. In November 2004, with the approval of the State-owned Assets Supervision and Administration Commission of the State Council, China Aquatic Products Corporation and China Animal Husbandry Industry and Commerce (Group) Corporation carried out a strategic reorganization to form China Agricultural Development Group The head office, Zhong Agricultural Development Group became the actual controller of Zhong Agricultural Development Co., Ltd. China Animal Husbandry Co., Ltd. now has 8 wholly-owned, controlled and joint venture biological products enterprises, 8 wholly-owned and controlled feed enterprises, and 4 wholly-owned and controlled veterinary medicine enterprises, with a total of more than 3,700 employees. Its business scope includes: animal biological products, feed, feed additives, veterinary medicine and animal husbandry means of production, as well as import and export trade of related products. It is a leading enterprise in China's animal husbandry industry. The company's main products account for more than one-third of the national market share, and the sales volume and market share of its main products are firmly among the top in the country. In 2007, the company achieved main business revenue of 1.721 billion yuan. As of the end of 2007, the company had total assets of 1.805 billion yuan and net assets of 1.097 billion yuan. China Animal Husbandry Co., Ltd. takes the corporate purpose of "protecting animal safety and caring for human health" and is always committed to the development, production, promotion and utilization of new, environmentally friendly, safe and green high-tech products. After years of unremitting efforts, it has been in animal health products and animals. The nutritional products industry has always been at an advanced level.
Tianjin Ribao Biotechnology Co., Ltd.
Rip Bio, as a well-known enterprise in my country's animal health products industry, focuses on the veterinary medicine field in China's A-share market. It adheres to the corporate philosophy of "foresight, innovation, integrity and sharing" to provide animal health and animal-derived food safety. , the solution to zoonotic diseases contributes to the strength. Rip Bio was founded in 1998 and has 20 subsidiaries and 5 research institutions, distributed in 8 provinces and cities including Beijing, Tianjin, Hubei, and Hunan. It has 84 large-scale production lines of various types, with more than 480 animal products such as livestock and poultry. It is a large-scale animal health product in China that integrates biological vaccines, drug raw materials, drug preparations, and word additives. Manufacturers and service providers.
Tianjin Ribao Biotechnology Co., Ltd.
Rip Bio, as a well-known enterprise in my country's animal health products industry, focuses on the veterinary medicine field in China's A-share market. It adheres to the corporate philosophy of "foresight, innovation, integrity and sharing" to provide animal health and animal-derived food safety. , the solution to zoonotic diseases contributes to the strength. Rip Bio was founded in 1998 and has 20 subsidiaries and 5 research institutions, distributed in 8 provinces and cities including Beijing, Tianjin, Hubei, and Hunan. It has 84 large-scale production lines of various types, with more than 480 animal products such as livestock and poultry. It is a large-scale animal health product in China that integrates biological vaccines, drug raw materials, drug preparations, and word additives. Manufacturers and service providers.
Shandong Xinde Technology Co., Ltd.
Founded in April 1999, Xinde Technology has always adhered to the core concept of "unswervingly increasing customer value", and with the fulcrum of animal protection business, it has become a service provider for agricultural and animal husbandry ecological construction, supporting the efficient and sustainable agricultural and animal husbandry industry. Development, make food safer and make rural areas better! Xinde Technology has always focused on animal care business, and has products in the entire industry chain such as veterinary biological products, veterinary Chinese chemical preparations, feed additives, diagnostic reagents, breeding management services, etc. It is a veterinary drug company with a wide range of products in the domestic veterinary drug industry. One of them is in an advanced domestic position in the fields of veterinary biological products, veterinary traditional Chinese chemical preparations, etc. The company has an advanced R&D laboratory in the industry, a professional R&D team, and has animal drug experiment conditions such as disease detection, product inspection, process research, etc., which can realize the full process of research from project establishment to industrial production; it has an animal disease detection center , Biologics R&D Center, Zhuzi Process Technology Platform, Xinda Testing Reagent R&D, Chinese Chemical Medicine R&D, Process and Quality Center, Clinical Application Research and other R&D teams; has 1 CNAS laboratory; has 3 national scientific research platforms: "National Certified Enterprise Technology Center", "2 Postdoctoral Research Stations"; 8 provincial scientific research platforms: "Shandong Provincial Engineering Research Center for Major Livestock and Poultry Epidemics", "Shandong Provincial Demonstration Engineering Technology Research Center", "Shandong Province" and "Shandong Province Scientific research platforms such as Biopharmaceutical Engineering Laboratory for Animals and "Shandong Provincial Animal Medicine Manufacturing Innovation Center".
Shandong Xinde Technology Co., Ltd.
Founded in April 1999, Xinde Technology has always adhered to the core concept of "unswervingly increasing customer value", and with the fulcrum of animal protection business, it has become a service provider for agricultural and animal husbandry ecological construction, supporting the efficient and sustainable agricultural and animal husbandry industry. Development, make food safer and make rural areas better! Xinde Technology has always focused on animal care business, and has products in the entire industry chain such as veterinary biological products, veterinary Chinese chemical preparations, feed additives, diagnostic reagents, breeding management services, etc. It is a veterinary drug company with a wide range of products in the domestic veterinary drug industry. One of them is in an advanced domestic position in the fields of veterinary biological products, veterinary traditional Chinese chemical preparations, etc. The company has an advanced R&D laboratory in the industry, a professional R&D team, and has animal drug experiment conditions such as disease detection, product inspection, process research, etc., which can realize the full process of research from project establishment to industrial production; it has an animal disease detection center , Biologics R&D Center, Zhuzi Process Technology Platform, Xinda Testing Reagent R&D, Chinese Chemical Medicine R&D, Process and Quality Center, Clinical Application Research and other R&D teams; has 1 CNAS laboratory; has 3 national scientific research platforms: "National Certified Enterprise Technology Center", "2 Postdoctoral Research Stations"; 8 provincial scientific research platforms: "Shandong Provincial Engineering Research Center for Major Livestock and Poultry Epidemics", "Shandong Provincial Demonstration Engineering Technology Research Center", "Shandong Province" and "Shandong Province Scientific research platforms such as Biopharmaceutical Engineering Laboratory for Animals and "Shandong Provincial Animal Medicine Manufacturing Innovation Center".
Qingdao Wellbio Co., Ltd.
Qingdao Weilan Biotech Co., Ltd. was registered and established in 2005. It is headquartered in Qingdao and currently has 1,430 employees. The company's main business is the research, development, production and sales of enzyme preparations, microecology, and animal health products. With the purpose of "Biotechnology Restores the Ecological World", the company is committed to providing core technical support for biomanufacturing, providing clean and energy-saving technologies for traditional industries, and providing green solutions for food safety, serving agriculture, animal husbandry, food, washing, textile and health throughout the process. , environmental protection and other industries. On January 16, 2019, Qingdao Weilan Biotech Co., Ltd. was listed on the A-share main board (stock code 603739). Qingdao Weilan Biotechnology Co., Ltd. and its subsidiaries have academician and expert workstations and postdoctoral research workstations. Qingdao Weilan Biotech Co., Ltd. and its subsidiaries have 252 domestic authorized invention patents, 5 US authorized patents, 1 European authorized patents, and 16 PCT patents, and have obtained 37 national new veterinary drug certificates (including 3 national first-class new veterinary drugs. ). In recent years, the company has presided over 33 national projects such as international cooperation projects and national 863 projects, and participated in 22 projects; presided over and participated in the formulation of 44 national and industry standards in the enzyme preparation and animal health industries, of which 40 have been promulgated and 4 are to be Issue.
Qingdao Wellbio Co., Ltd.
Qingdao Weilan Biotech Co., Ltd. was registered and established in 2005. It is headquartered in Qingdao and currently has 1,430 employees. The company's main business is the research, development, production and sales of enzyme preparations, microecology, and animal health products. With the purpose of "Biotechnology Restores the Ecological World", the company is committed to providing core technical support for biomanufacturing, providing clean and energy-saving technologies for traditional industries, and providing green solutions for food safety, serving agriculture, animal husbandry, food, washing, textile and health throughout the process. , environmental protection and other industries. On January 16, 2019, Qingdao Weilan Biotech Co., Ltd. was listed on the A-share main board (stock code 603739). Qingdao Weilan Biotechnology Co., Ltd. and its subsidiaries have academician and expert workstations and postdoctoral research workstations. Qingdao Weilan Biotech Co., Ltd. and its subsidiaries have 252 domestic authorized invention patents, 5 US authorized patents, 1 European authorized patents, and 16 PCT patents, and have obtained 37 national new veterinary drug certificates (including 3 national first-class new veterinary drugs. ). In recent years, the company has presided over 33 national projects such as international cooperation projects and national 863 projects, and participated in 22 projects; presided over and participated in the formulation of 44 national and industry standards in the enzyme preparation and animal health industries, of which 40 have been promulgated and 4 are to be Issue.
Zoetis (Suzhou) Animal Health Products Co., Ltd.
Zoetis ( zō-EH-tis ), whose root is zo, is well known as zoo (zoo) and zoology (zoology). Zoetis originated from zoetic (living, alive), and contains the meaning of "the meaning given to life". Zoetis is committed to supporting veterinary and livestock practitioners who raise and care for animals around the world. Zoten, as a world-renowned animal health company, is committed to leading animal care and building a healthy world together. Over the past 70 years, the company has continued to innovate, providing chemical drugs, vaccines, diagnostic products and professional technical services to more than 100 countries around the world, and providing all-round care to animals. Adhering to seventy years of industry experience and dedicated focus on animal health, we provide innovative products to veterinarians, livestock practitioners and pet owners, covering all aspects of prevention, testing, diagnosis and treatment. Zoten has set up R&D centers in many countries and regions around the world. Zoten Global R&D Center is currently headquartered in Kalamazoo, Michigan, USA. Zoten China R&D Center includes Beijing R&D Laboratory, Suzhou R&D Laboratory and Suzhou Animal Facilities.
Zoetis (Suzhou) Animal Health Products Co., Ltd.
Zoetis ( zō-EH-tis ), whose root is zo, is well known as zoo (zoo) and zoology (zoology). Zoetis originated from zoetic (living, alive), and contains the meaning of "the meaning given to life". Zoetis is committed to supporting veterinary and livestock practitioners who raise and care for animals around the world. Zoten, as a world-renowned animal health company, is committed to leading animal care and building a healthy world together. Over the past 70 years, the company has continued to innovate, providing chemical drugs, vaccines, diagnostic products and professional technical services to more than 100 countries around the world, and providing all-round care to animals. Adhering to seventy years of industry experience and dedicated focus on animal health, we provide innovative products to veterinarians, livestock practitioners and pet owners, covering all aspects of prevention, testing, diagnosis and treatment. Zoten has set up R&D centers in many countries and regions around the world. Zoten Global R&D Center is currently headquartered in Kalamazoo, Michigan, USA. Zoten China R&D Center includes Beijing R&D Laboratory, Suzhou R&D Laboratory and Suzhou Animal Facilities.
Elanco (Shanghai) Animal Health Co., Ltd.
Lilan Animal Protection provides solutions for customers who raise and care for animals to realize the vision of continuously enriching our lives with food and companion animals. Healthy animals can create a better life. Companion animals are becoming more and more important in our lives, so we want to make them live longer, healthier and better. As the global population grows, humans need more safe and affordable food to meet the needs of the public. Since Eli Lilly established the Ministry of Animal Health in 1954, Lilly Animal has been committed to helping veterinarians, food manufacturers and people who are concerned about animal health to meet global challenges and realize the vision of continuously enriching our lives with food and companion animals. Through innovation, develop safe products for customers, animals and the environment, and realize the common vision of enriching human life.
Elanco (Shanghai) Animal Health Co., Ltd.
Lilan Animal Protection provides solutions for customers who raise and care for animals to realize the vision of continuously enriching our lives with food and companion animals. Healthy animals can create a better life. Companion animals are becoming more and more important in our lives, so we want to make them live longer, healthier and better. As the global population grows, humans need more safe and affordable food to meet the needs of the public. Since Eli Lilly established the Ministry of Animal Health in 1954, Lilly Animal has been committed to helping veterinarians, food manufacturers and people who are concerned about animal health to meet global challenges and realize the vision of continuously enriching our lives with food and companion animals. Through innovation, develop safe products for customers, animals and the environment, and realize the common vision of enriching human life.
Wens Foodstuff Group Co., Ltd.
Dahuanong is one of the wholly-owned subsidiaries of Wen's Food Group Co., Ltd. (hereinafter referred to as "Wen's Shares", stock code: 300498), with its main business of veterinary biological products, veterinary drug preparations, and feed additives. With the mission of "being an animal health expert and serving human health", the company is committed to the research, development, production and promotion of ecological, green and environmentally friendly high-tech products of animal health products. It is a highly pathogenic avian influenza vaccine designated by the Ministry of Agriculture and Rural Affairs. Manufacturing enterprise. After the asset restructuring was completed at the end of 2020, Zhaoqing Dahua Agricultural Biopharmaceuticals Co., Ltd. was the main body, and its subsidiaries include Guangdong Wenshi Dahua Agricultural Biotechnology Co., Ltd., Xinxing Dahua Agricultural Poultry Egg Co., Ltd., and Foshan Zhengdian Biotechnology Co., Ltd.; Management Four production bases with international advanced technology levels - Guangdong Province Zhaoqing National High-tech Zone, Yunfu Xinxing County Wenshi Science and Technology Park, Xincheng Industrial Park, and Foshan Sanshui District, has 7,000 square meters of biosafety third-level protective vaccine production workshop More than 40 GMP production lines that have passed the acceptance acceptance of the Ministry of Agriculture and Rural Affairs, as well as the experimental animal center with an annual output of 1.5 million SPF eggs, have obtained more than 50 vaccine product production approval documents, and have 400 production approval documents for veterinary drugs and additive products such as poultry and livestock. Multiple. The "Dahuanong" brand's veterinary biological products, veterinary drug preparations, feed additives, and Zhengdian basin seedlings have excellent quality and have won wide recognition from the industry and customers. The company's products are the purchase target of domestic breeding giants, and are also exported to the Middle East and Southeast Asia regions such as Egypt, Indonesia, and Vietnam. They have been recognized by foreign customers and have been unanimously praised by domestic and foreign governments, veterinary experts and livestock enterprises. The company has first-class animal disease detection equipment and functional laboratories, has diagnostic reagent workshops, and has African swine fever fluorescent PCR detection technology, avian leukemia virus ELISA antibody detection technology, etc., which can provide customers with full-process services for animal disease prevention and control technology. , including comprehensive experimental diagnosis and antibody testing of livestock and poultry epidemics, vaccine quality testing and vaccine protection assessment, providing a complete set of solutions for breeding and production and veterinary problems, advanced veterinary experimental technology training, new disease detection technologies and related kit research and development and Test evaluation, etc.
Wens Foodstuff Group Co., Ltd.
Dahuanong is one of the wholly-owned subsidiaries of Wen's Food Group Co., Ltd. (hereinafter referred to as "Wen's Shares", stock code: 300498), with its main business of veterinary biological products, veterinary drug preparations, and feed additives. With the mission of "being an animal health expert and serving human health", the company is committed to the research, development, production and promotion of ecological, green and environmentally friendly high-tech products of animal health products. It is a highly pathogenic avian influenza vaccine designated by the Ministry of Agriculture and Rural Affairs. Manufacturing enterprise. After the asset restructuring was completed at the end of 2020, Zhaoqing Dahua Agricultural Biopharmaceuticals Co., Ltd. was the main body, and its subsidiaries include Guangdong Wenshi Dahua Agricultural Biotechnology Co., Ltd., Xinxing Dahua Agricultural Poultry Egg Co., Ltd., and Foshan Zhengdian Biotechnology Co., Ltd.; Management Four production bases with international advanced technology levels - Guangdong Province Zhaoqing National High-tech Zone, Yunfu Xinxing County Wenshi Science and Technology Park, Xincheng Industrial Park, and Foshan Sanshui District, has 7,000 square meters of biosafety third-level protective vaccine production workshop More than 40 GMP production lines that have passed the acceptance acceptance of the Ministry of Agriculture and Rural Affairs, as well as the experimental animal center with an annual output of 1.5 million SPF eggs, have obtained more than 50 vaccine product production approval documents, and have 400 production approval documents for veterinary drugs and additive products such as poultry and livestock. Multiple. The "Dahuanong" brand's veterinary biological products, veterinary drug preparations, feed additives, and Zhengdian basin seedlings have excellent quality and have won wide recognition from the industry and customers. The company's products are the purchase target of domestic breeding giants, and are also exported to the Middle East and Southeast Asia regions such as Egypt, Indonesia, and Vietnam. They have been recognized by foreign customers and have been unanimously praised by domestic and foreign governments, veterinary experts and livestock enterprises. The company has first-class animal disease detection equipment and functional laboratories, has diagnostic reagent workshops, and has African swine fever fluorescent PCR detection technology, avian leukemia virus ELISA antibody detection technology, etc., which can provide customers with full-process services for animal disease prevention and control technology. , including comprehensive experimental diagnosis and antibody testing of livestock and poultry epidemics, vaccine quality testing and vaccine protection assessment, providing a complete set of solutions for breeding and production and veterinary problems, advanced veterinary experimental technology training, new disease detection technologies and related kit research and development and Test evaluation, etc.
Baoding Jizhong Pharmaceutical Co., Ltd.
Baoding Jizhong Pharmaceutical Co., Ltd. is a private enterprise integrating R&D, production, sales and service of veterinary drug preparations and raw materials manufacturing. It was founded in 1992 with a registered capital of 104 million yuan. It adheres to the concept of "green, natural health" and guides it. Veterinary drug preparation development. There are three automated, informatized and modern veterinary drug preparation GMP production bases in Gaoyang and Qingyuan, Baoding, and a raw material drug preparation GMP production base in Neiqiu, Xingtai. It has formed a close cooperative relationship with more than 95% of the large-scale breeding groups in China, and its products are widely used in breeding fields such as pigs, poultry, rumination, aquatic products, and companion animals. The international market is exported to more than 40 countries in Southeast Asia, the Middle East, Africa and South America. The company is a national high-tech enterprise and a key leading enterprise in agricultural industrialization in Hebei Province. The company adheres to the innovation strategy of "how far the R&D goes, how far the enterprise can go", and actively carries out independent research and development and joint development. The Hebei Provincial Traditional Chinese Veterinary Medicine Technology Innovation Center, Hebei Provincial Livestock and Poultry Drug Technology Innovation Center, and Hebei Provincial Enterprise Technology Center, have more than 80 full-time R&D personnel composed of doctoral and master's students. The R&D center was rated as A-level R&D institution of provincial industrial enterprises, and the R&D team was awarded the Provincial Giant Team. At the same time, the company has carried out industry-university-research cooperation with major domestic agricultural institutes such as Zhejiang University, China Agricultural University, Northwest Agriculture and Forestry, Lanzhou Institute, and Harbin Institute of Veterinary Research. It has jointly built the Institute of Animal Nutrition with the Shibo Researcher Team of the Chinese Academy of Agricultural Sciences, and has worked with Zhang Wenqin, Tianjin University. The professor's team jointly built the Institute of Raw Materials and Drugs, and conducted process technology commissioned research and development with Tsinghua University, Ningxia University, Peking University, Hunan University, etc. It has obtained 24 new veterinary drug certificates, 37 national invention patents, 33 provincial scientific and technological achievements, presided over and participated in the formulation of 28 national industry standards, and participated in the national 12th, 13th, and 14th Five-Year Plans of the National Science and Technology Support Plan. High-quality products have actively promoted the development of the industry. Jizhong has taken Chuanchuang Chinese Veterinary Medicine as its mission, and has achieved certain results in promoting the reduction of antibiotic use in the breeding industry, preventing and controlling African swine fever in traditional Chinese medicine, reducing costs and increasing efficiency. The company processed and used more than 3,000 tons of Chinese medicinal materials such as Forsythia, honeysuckle, scutellaria baicalensis, coptis chinensis, astragalus, licorice, isatis root, and big green leaves. It has driven the planting of about 10,000 mu of Chinese medicinal materials, benefiting more than 6,000 farmers, and some of them have been realized. Chinese medicinal materials contract planting and base procurement. Hebei Central directly participates in the drafting of the development of veterinary medicines in the 12th Five-Year Plan, 13th Five-Year Plan, 14th Five-Year Plan, participates in the national science and technology support plan for 12th Five-Year Plan, and drafts the development plan for medium- and long-term (2018-2025) of Chinese veterinary medicines. "Announcement 420 of the Ministry of Agriculture and Rural Affairs" is one of the 10 major participating enterprises, namely the vice president of the China Veterinary Medicine Association, a national high-tech enterprise, and a key leading enterprise in the province's agricultural industrialization. "Seeking endlessly, innovation endlessly" In the future, Hebei Central will continue to play the role of the industry, and be committed to the vision of "making breeding greener and healthier", and build it into an excellent domestic veterinary drug preparation enterprise to provide more professional and higher quality for the breeding industry. , more stable and safer products and services, and make due contributions to anti-resistance and low-resistance breeding and food safety.
Baoding Jizhong Pharmaceutical Co., Ltd.
Baoding Jizhong Pharmaceutical Co., Ltd. is a private enterprise integrating R&D, production, sales and service of veterinary drug preparations and raw materials manufacturing. It was founded in 1992 with a registered capital of 104 million yuan. It adheres to the concept of "green, natural health" and guides it. Veterinary drug preparation development. There are three automated, informatized and modern veterinary drug preparation GMP production bases in Gaoyang and Qingyuan, Baoding, and a raw material drug preparation GMP production base in Neiqiu, Xingtai. It has formed a close cooperative relationship with more than 95% of the large-scale breeding groups in China, and its products are widely used in breeding fields such as pigs, poultry, rumination, aquatic products, and companion animals. The international market is exported to more than 40 countries in Southeast Asia, the Middle East, Africa and South America. The company is a national high-tech enterprise and a key leading enterprise in agricultural industrialization in Hebei Province. The company adheres to the innovation strategy of "how far the R&D goes, how far the enterprise can go", and actively carries out independent research and development and joint development. The Hebei Provincial Traditional Chinese Veterinary Medicine Technology Innovation Center, Hebei Provincial Livestock and Poultry Drug Technology Innovation Center, and Hebei Provincial Enterprise Technology Center, have more than 80 full-time R&D personnel composed of doctoral and master's students. The R&D center was rated as A-level R&D institution of provincial industrial enterprises, and the R&D team was awarded the Provincial Giant Team. At the same time, the company has carried out industry-university-research cooperation with major domestic agricultural institutes such as Zhejiang University, China Agricultural University, Northwest Agriculture and Forestry, Lanzhou Institute, and Harbin Institute of Veterinary Research. It has jointly built the Institute of Animal Nutrition with the Shibo Researcher Team of the Chinese Academy of Agricultural Sciences, and has worked with Zhang Wenqin, Tianjin University. The professor's team jointly built the Institute of Raw Materials and Drugs, and conducted process technology commissioned research and development with Tsinghua University, Ningxia University, Peking University, Hunan University, etc. It has obtained 24 new veterinary drug certificates, 37 national invention patents, 33 provincial scientific and technological achievements, presided over and participated in the formulation of 28 national industry standards, and participated in the national 12th, 13th, and 14th Five-Year Plans of the National Science and Technology Support Plan. High-quality products have actively promoted the development of the industry. Jizhong has taken Chuanchuang Chinese Veterinary Medicine as its mission, and has achieved certain results in promoting the reduction of antibiotic use in the breeding industry, preventing and controlling African swine fever in traditional Chinese medicine, reducing costs and increasing efficiency. The company processed and used more than 3,000 tons of Chinese medicinal materials such as Forsythia, honeysuckle, scutellaria baicalensis, coptis chinensis, astragalus, licorice, isatis root, and big green leaves. It has driven the planting of about 10,000 mu of Chinese medicinal materials, benefiting more than 6,000 farmers, and some of them have been realized. Chinese medicinal materials contract planting and base procurement. Hebei Central directly participates in the drafting of the development of veterinary medicines in the 12th Five-Year Plan, 13th Five-Year Plan, 14th Five-Year Plan, participates in the national science and technology support plan for 12th Five-Year Plan, and drafts the development plan for medium- and long-term (2018-2025) of Chinese veterinary medicines. "Announcement 420 of the Ministry of Agriculture and Rural Affairs" is one of the 10 major participating enterprises, namely the vice president of the China Veterinary Medicine Association, a national high-tech enterprise, and a key leading enterprise in the province's agricultural industrialization. "Seeking endlessly, innovation endlessly" In the future, Hebei Central will continue to play the role of the industry, and be committed to the vision of "making breeding greener and healthier", and build it into an excellent domestic veterinary drug preparation enterprise to provide more professional and higher quality for the breeding industry. , more stable and safer products and services, and make due contributions to anti-resistance and low-resistance breeding and food safety.
Qilu Animal Health Products Co., Ltd.
Qilu Animal Health Products Co., Ltd. was founded in 1958 and is affiliated to Qilu Pharmaceutical Group Co., Ltd. It is a large-scale comprehensive integration of the research, development, production and sales of animal chemicals, animal biological products, animal raw materials and feed additives. Modern animal health products enterprises. The company currently has three production bases: Gongbei Factory, Dongjia Base Chemical Pharmaceutical Preparation Park and Dongjiasheng Pharmaceutical Factory. It has 27 GMP workshops, 42 GMP production lines, and 172 product approval numbers. The company has always adhered to the innovation-driven strategy, focused on R&D, and created high-quality products, aiming to express our love with technology, be committed to the cause of animation and care for human health. He has won 3 National Science and Technology Progress Awards, 10 Provincial Science and Technology Progress Awards, and 2 Shennong Chinese Agricultural Science and Technology Awards of the Ministry of Agriculture. There are more than 180 full-time R&D personnel, 5 doctoral students, and more than 50% of them are in the proportion of master's degree or above. Four provincial R&D platforms have been established, including Shandong Province's Key Laboratory for the Creation Technology of New Veterinary Drugs for Major Animal Diseases, Shandong Province's Veterinary Chemical Drug Engineering Technology Research Center, Shandong Province's Enterprise Technology Center, and Shandong Province's Veterinary Biological Products Engineering Laboratory. Since 2007, the company has obtained a total of 62 national new veterinary drug registration certificates, 4 new veterinary drugs in Class I and 15 new veterinary drugs in Class II. Among them, 32 chemical drugs were found, accounting for 12.6% of the total number of chemical drugs new veterinary drug certificates issued nationwide during the same period (230 items). The company has a FDA standard freeze-dried live vaccine production line, a large domestic suspension culture production line, and a large domestic lyophilized preparation production workshop. It has a leading domestic large-scale cell suspension culture technology. The Animal Chemical Pharmaceutical Preparation Park, which was officially put into production in November 2020, covers an area of 258.91 mu, with a total investment of approximately 2.19 billion yuan. It plans to build 8 production workshops, 2 warehouses, and corresponding supporting facilities such as power, fire protection, and sewage treatment. Design and construction with the Industrial 4.0 architecture, fully in line with international standards such as the United States and the European Union. Introduce internationally leading intelligent logistics, robotics technology, power control, WMS/SCADA and other information control systems, which have lean, digital, visual and intelligent characteristics. The company has established a GMP quality management and control system that is in line with international standards, introduced international advanced testing instruments and testing technologies, accelerated its integration with international standards such as FDA and COS, and all employees have fully implemented GMP management throughout the process to ensure product quality. 22 new veterinary drug products are included in the national veterinary drug comparison test catalog as reference preparations, nearly 20 product quality standards are included in the national veterinary drug copyright, and 18 products provide standard substances as national standard products. The products are sold in nearly 30 countries and regions including Europe, North America, Australia, Russia, South Africa, Latin America. Qilu Animal Protection is deeply engaged in the industrial layout of animal health care, building a complete and rich product form, and escorting every step of animal growth. The company will take the health of thousands of lives as its lofty mission and is committed to building the world's number one brand in the animal care industry, constantly improving itself and surpassing itself, and providing more high-quality, efficient and safe animal health products for the animal husbandry industry.
Qilu Animal Health Products Co., Ltd.
Qilu Animal Health Products Co., Ltd. was founded in 1958 and is affiliated to Qilu Pharmaceutical Group Co., Ltd. It is a large-scale comprehensive integration of the research, development, production and sales of animal chemicals, animal biological products, animal raw materials and feed additives. Modern animal health products enterprises. The company currently has three production bases: Gongbei Factory, Dongjia Base Chemical Pharmaceutical Preparation Park and Dongjiasheng Pharmaceutical Factory. It has 27 GMP workshops, 42 GMP production lines, and 172 product approval numbers. The company has always adhered to the innovation-driven strategy, focused on R&D, and created high-quality products, aiming to express our love with technology, be committed to the cause of animation and care for human health. He has won 3 National Science and Technology Progress Awards, 10 Provincial Science and Technology Progress Awards, and 2 Shennong Chinese Agricultural Science and Technology Awards of the Ministry of Agriculture. There are more than 180 full-time R&D personnel, 5 doctoral students, and more than 50% of them are in the proportion of master's degree or above. Four provincial R&D platforms have been established, including Shandong Province's Key Laboratory for the Creation Technology of New Veterinary Drugs for Major Animal Diseases, Shandong Province's Veterinary Chemical Drug Engineering Technology Research Center, Shandong Province's Enterprise Technology Center, and Shandong Province's Veterinary Biological Products Engineering Laboratory. Since 2007, the company has obtained a total of 62 national new veterinary drug registration certificates, 4 new veterinary drugs in Class I and 15 new veterinary drugs in Class II. Among them, 32 chemical drugs were found, accounting for 12.6% of the total number of chemical drugs new veterinary drug certificates issued nationwide during the same period (230 items). The company has a FDA standard freeze-dried live vaccine production line, a large domestic suspension culture production line, and a large domestic lyophilized preparation production workshop. It has a leading domestic large-scale cell suspension culture technology. The Animal Chemical Pharmaceutical Preparation Park, which was officially put into production in November 2020, covers an area of 258.91 mu, with a total investment of approximately 2.19 billion yuan. It plans to build 8 production workshops, 2 warehouses, and corresponding supporting facilities such as power, fire protection, and sewage treatment. Design and construction with the Industrial 4.0 architecture, fully in line with international standards such as the United States and the European Union. Introduce internationally leading intelligent logistics, robotics technology, power control, WMS/SCADA and other information control systems, which have lean, digital, visual and intelligent characteristics. The company has established a GMP quality management and control system that is in line with international standards, introduced international advanced testing instruments and testing technologies, accelerated its integration with international standards such as FDA and COS, and all employees have fully implemented GMP management throughout the process to ensure product quality. 22 new veterinary drug products are included in the national veterinary drug comparison test catalog as reference preparations, nearly 20 product quality standards are included in the national veterinary drug copyright, and 18 products provide standard substances as national standard products. The products are sold in nearly 30 countries and regions including Europe, North America, Australia, Russia, South Africa, Latin America. Qilu Animal Protection is deeply engaged in the industrial layout of animal health care, building a complete and rich product form, and escorting every step of animal growth. The company will take the health of thousands of lives as its lofty mission and is committed to building the world's number one brand in the animal care industry, constantly improving itself and surpassing itself, and providing more high-quality, efficient and safe animal health products for the animal husbandry industry.
Merck Sharp & Dohme (China) Investment Co., Ltd.
For 130 years, Merck has always followed the mission of saving lives and improving lives, committed to enhancing life and bringing medicines and vaccines to overcome difficult diseases around the world. Through far-reaching policies, programs and partnerships, Merck fulfills its commitment to improve access to health care for patients and the general public. Today, Merck continues to be at the forefront of R&D, promoting its prevention and treatment of diseases that threaten human and animal health around the world—including cancer, infectious diseases such as HIV and Ebola viruses and emerging animal diseases. Merck focuses on scientific research and innovation, exploration, development, and provides drugs and vaccines that benefit millions of people around the world. Vaccines are one of the most effective areas of public health - Merck has been constantly exploring, developing and providing vaccines for disease prevention over the course of a century. Merck has played an important role in exploring, developing innovative drugs and vaccines for the treatment and prevention of infectious diseases. Merck is committed to finding solutions to severe chronic diseases such as cardiovascular disease and diabetes. Merck Animal Health is driven by research and develop, produce and sell a wide range of veterinary medicines and services. Whether it is R&D, manufacturing or sales, Merck's animal health business is a leader in the global market. Products cover the prevention, treatment and control of diseases in poultry and pets. China is a crucial part of Merck's global growth strategy. Merck China is headquartered in Shanghai, with a R&D center in Beijing and a factory in Hangzhou, realizing the integration of R&D, manufacturing and commercial operations. Merck is wholeheartedly providing high-quality innovative drugs, vaccines and services to the Chinese public to benefit Chinese society.
Merck Sharp & Dohme (China) Investment Co., Ltd.
For 130 years, Merck has always followed the mission of saving lives and improving lives, committed to enhancing life and bringing medicines and vaccines to overcome difficult diseases around the world. Through far-reaching policies, programs and partnerships, Merck fulfills its commitment to improve access to health care for patients and the general public. Today, Merck continues to be at the forefront of R&D, promoting its prevention and treatment of diseases that threaten human and animal health around the world—including cancer, infectious diseases such as HIV and Ebola viruses and emerging animal diseases. Merck focuses on scientific research and innovation, exploration, development, and provides drugs and vaccines that benefit millions of people around the world. Vaccines are one of the most effective areas of public health - Merck has been constantly exploring, developing and providing vaccines for disease prevention over the course of a century. Merck has played an important role in exploring, developing innovative drugs and vaccines for the treatment and prevention of infectious diseases. Merck is committed to finding solutions to severe chronic diseases such as cardiovascular disease and diabetes. Merck Animal Health is driven by research and develop, produce and sell a wide range of veterinary medicines and services. Whether it is R&D, manufacturing or sales, Merck's animal health business is a leader in the global market. Products cover the prevention, treatment and control of diseases in poultry and pets. China is a crucial part of Merck's global growth strategy. Merck China is headquartered in Shanghai, with a R&D center in Beijing and a factory in Hangzhou, realizing the integration of R&D, manufacturing and commercial operations. Merck is wholeheartedly providing high-quality innovative drugs, vaccines and services to the Chinese public to benefit Chinese society.
Henan Dayong Industrial Co., Ltd.
Henan Dayong (Group) Industrial Co., Ltd. (hereinafter referred to as Dayong Group) was established in May 1984. Under the leadership of the Chairman Mr. Du Wenjun's corporate spirit of "thrift, integrity, dedication and striving for talent", it has developed after years of entrepreneurship and innovation. It has become a large agricultural, animal husbandry and food enterprise group integrating breeding of good varieties, feed processing, chicken hatching, broiler breeding, slaughtering and processing, deep processing of conditioning products, technology research and development, vaccine production, cold chain logistics, packaging and color printing, etc. Currently, Dayong Group owns Henan Dayong Industrial Co., Ltd., Hebi Dayong Animal Husbandry Co., Ltd., Jiaozuo Dayong Industrial Co., Ltd., Henan Dayong Bangjie Food Co., Ltd., Kaifeng Dayong Industrial Co., Ltd., Xihua Dayong More than 20 subsidiaries and holding companies including Fuxi Agricultural and Animal Husbandry Development Co., Ltd. and Hebi Shenkang Bioproducts Co., Ltd. Dayong Group adheres to the full-industry chain development model of "self-producing, self-raising, self-producing, self-selling" broiler, and has formed a strict food safety traceability system "from farmland to dining table". The company's products are sold to more than 20 provinces, cities and autonomous regions in China, as well as countries and regions such as Japan, South Korea, and the Middle East. In the future, Dayong Group faces a new global competitive landscape and establishes the development concept of "rooted agriculture and serving the world" and the strategic goal of "being a world-wide agricultural and animal husbandry enterprise", challenging itself and challenging the future, and serving the agricultural, animal husbandry and food industry in China. People continue to innovate by making their own world brand.
Henan Dayong Industrial Co., Ltd.
Henan Dayong (Group) Industrial Co., Ltd. (hereinafter referred to as Dayong Group) was established in May 1984. Under the leadership of the Chairman Mr. Du Wenjun's corporate spirit of "thrift, integrity, dedication and striving for talent", it has developed after years of entrepreneurship and innovation. It has become a large agricultural, animal husbandry and food enterprise group integrating breeding of good varieties, feed processing, chicken hatching, broiler breeding, slaughtering and processing, deep processing of conditioning products, technology research and development, vaccine production, cold chain logistics, packaging and color printing, etc. Currently, Dayong Group owns Henan Dayong Industrial Co., Ltd., Hebi Dayong Animal Husbandry Co., Ltd., Jiaozuo Dayong Industrial Co., Ltd., Henan Dayong Bangjie Food Co., Ltd., Kaifeng Dayong Industrial Co., Ltd., Xihua Dayong More than 20 subsidiaries and holding companies including Fuxi Agricultural and Animal Husbandry Development Co., Ltd. and Hebi Shenkang Bioproducts Co., Ltd. Dayong Group adheres to the full-industry chain development model of "self-producing, self-raising, self-producing, self-selling" broiler, and has formed a strict food safety traceability system "from farmland to dining table". The company's products are sold to more than 20 provinces, cities and autonomous regions in China, as well as countries and regions such as Japan, South Korea, and the Middle East. In the future, Dayong Group faces a new global competitive landscape and establishes the development concept of "rooted agriculture and serving the world" and the strategic goal of "being a world-wide agricultural and animal husbandry enterprise", challenging itself and challenging the future, and serving the agricultural, animal husbandry and food industry in China. People continue to innovate by making their own world brand.
Anivive Lifesciences focuses on developing innovative veterinary therapeutics and diagnostics, aiming to improve the health and longevity of companion animals.
Anivive Lifesciences
Anivive Lifesciences focuses on developing innovative veterinary therapeutics and diagnostics, aiming to improve the health and longevity of companion animals.
Vemag provides advanced sealing machines for the food industry, known for their precision and efficiency.
Vemag Maschinenbau GmbH
Vemag provides advanced sealing machines for the food industry, known for their precision and efficiency.
Huvepharma provides a range of animal health and nutrition products, including feed additives and vaccines, to support animal well-being and performance.
Huvepharma
Huvepharma provides a range of animal health and nutrition products, including feed additives and vaccines, to support animal well-being and performance.
